Your browser doesn't support javascript.
loading
Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.
Pitkänen, Niina; Finkenstedt, Armin; Lamina, Claudia; Juonala, Markus; Kähönen, Mika; Mäkelä, Kari-Matti; Dieplinger, Benjamin; Viveiros, Andre; Melmer, Andreas; Leitner, Isabella; Kedenko, Ludmilla; Seppälä, Ilkka; Viikari, Jorma S A; Mueller, Thomas; Kronenberg, Florian; Paulweber, Bernhard; Lehtimäki, Terho; Zoller, Heinz; Raitakari, Olli T; Dieplinger, Hans.
Afiliación
  • Pitkänen N; Research Centre for Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Finkenstedt A; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
  • Lamina C; Department of Genetics and Pharmacology, Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Juonala M; Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
  • Kähönen M; Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Mäkelä KM; Department of Clinical Physiology, Tampere University Hospital, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Dieplinger B; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Viveiros A; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
  • Melmer A; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
  • Leitner I; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
  • Kedenko L; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
  • Seppälä I; First Department of Internal Medicine I, Paracelsus Medical University Salzburg, Austria.
  • Viikari JSA; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Mueller T; Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
  • Kronenberg F; Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Paulweber B; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
  • Lehtimäki T; Department of Genetics and Pharmacology, Institute of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Zoller H; First Department of Internal Medicine I, Paracelsus Medical University Salzburg, Austria.
  • Raitakari OT; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Dieplinger H; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
Clin Chem Lab Med ; 60(2): 243-251, 2022 01 27.
Article en En | MEDLINE | ID: mdl-34850615

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteínas / Proteínas Portadoras / Enfermedad del Hígado Graso no Alcohólico / Albúmina Sérica Humana Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2022 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteínas / Proteínas Portadoras / Enfermedad del Hígado Graso no Alcohólico / Albúmina Sérica Humana Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2022 Tipo del documento: Article País de afiliación: Finlandia
...